Oncologist assessed the prospects of using oncovaccines in Russia
The combined use of oncovaccines and CAR-T-cell therapy does not yet allow accurate prediction of the duration of remission in patients. On April 7, an oncologist at the Sberbank Health medical company, Suna Isakova, told Izvestia about this.
According to the specialist, the duration of remission in oncological diseases depends on many factors, including the molecular features of the tumor, its localization, the presence of metastases and the characteristics of the microenvironment.
"For each group of patients, the life expectancy without a return of the disease is individual," Isakova explained.
She noted that the combined treatment with CAR-T therapy and oncovaccines has not yet passed a sufficient number of clinical observations, so it is premature to make accurate predictions.
The expert also pointed out that CAR-T-cell therapy can be accompanied by serious side effects, including cytokine release syndrome, neurotoxicity, decreased blood cell levels and other complications.
"The management of patients with side effects depends on their severity, and in some cases it may be necessary to use expensive drugs or inpatient treatment in large centers," she added.
According to her, the issue of the readiness of regional hospitals to deal with such complications remains open and requires an assessment of the infrastructure and qualifications of specialists. In addition, there is still insufficient data on how the new Russian cancer vaccines will be combined with radiation and chemotherapy and whether they will be able to increase overall patient survival.
Isakova stressed that today we are talking about only isolated cases of using a combined approach, but the emergence of new treatment methods gives reason to expect improved treatment results in the future.
On April 6, Prime Minister Mikhail Mishustin announced that the government had expanded the state guarantee program and included treatment with Russian cancer vaccines in the compulsory health insurance system. He noted that the policy made available the treatment of certain types of blood diseases, cancer of internal organs, as well as CAR-T cell therapy.
All important news is on the Izvestia channel in the MAX messenger.
Переведено сервисом «Яндекс Переводчик»